Adial pharmaceuticals provides letter to shareholders from ceo william stilley

Charlottesville, va., june 28, 2022 (globe newswire) -- adial pharmaceuticals, inc. (nasdaq: adil; adilw) (“adial” or the “company”), today issued the following letter to its shareholders from the company's ceo, william stilley.

ADIL Ratings Summary

ADIL Quant Ranking